Hirotomo Kato

Prof. Hirotomo Kato

Jichi Medical University
orcid

Research Focus & Metrics

Academic Career Length

33Years (1994-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 May 2019 in The Lancet Infectious Diseases
Verified
Journal Article
Open access
MGMaria E Grillet
Maria E Grillet
JHJuan V Hernández-Villena
Juan V Hernández-Villena
MLMartin S. Llewellyn
Martin S. Llewellyn
APAlberto E Paniz-Mondolfi
Alberto E Paniz-Mondolfi
ATAdriana Tami
Adriana Tami
BNBelkisyolé Alarcón-De Noya
Belkisyolé Alarcón-De Noya
In the past 5-10 years, Venezuela has faced a severe economic crisis, precipitated by political instability and declining oil revenue. Public health provision has been affected particularly. In this Review, we assess the impact of Venezuela's health-care crisis on vector-borne diseases, and the spillover into neighbouring countries. Between 2000 and 2015, Venezuela witnessed a 359% increase in malaria cases, followed by a 71% increase in 2017 (411 586 cases) compared with 2016 (240 613). Neighbouring countries, such as Brazil, have reported an escalating trend of imported malaria cases from Venezuela, from 1538 in 2014 to 3129 in 2017. In Venezuela, active Chagas disease transmission has been reported, with seroprevalence in children (<10 years), estimated to be as high as 12·5% in one community tested (n=64). Dengue incidence increased by more than four times between 1990 and 2016. The estimated incidence of chikungunya during its epidemic peak is 6975 cases per 100 000 people and that of Zika virus is 2057 cases per 100 000 people. The re-emergence of many vector-borne diseases represents a public health crisis in Venezuela and has the possibility of severely undermining regional disease elimination efforts. National, regional, and global authorities must take action to address these worsening epidemics and prevent their expansion beyond Venezuelan borders.

7 November 2019 in PLOS Neglected Tropical Diseases
Verified
Journal Article
Open access
CNChukwunonso Nzelu
Chukwunonso Nzelu
HKHirotomo Kato
Hirotomo Kato
NPNathan C Peters
Nathan C Peters
Leishmaniasis, caused by protozoan parasites of the Leishmania genus, represents an important health problem in many regions of the world. Lack of effective point-of-care (POC) diagnostic tests applicable in resources-limited endemic areas is a critical barrier to effective treatment and control of leishmaniasis. The development of the loop-mediated isothermal amplification (LAMP) assay has provided a new tool towards the development of a POC diagnostic test based on the amplification of pathogen DNA. LAMP does not require a thermocycler, is relatively inexpensive, and is simple to perform with high amplification sensitivity and specificity. In this review, we discuss the current technical developments, applications, diagnostic performance, challenges, and future of LAMP for molecular diagnosis and surveillance of Leishmania parasites. Studies employing the LAMP assay to diagnose human leishmaniasis have reported sensitivities of 80% to 100% and specificities of 94% to 100%. These observations suggest that LAMP offers a good molecular POC technique for the diagnosis of leishmaniasis and is also readily applicable to screening at-risk populations and vector sand flies for Leishmania infection in endemic areas.

1 January 2005 in The American Journal of Tropical Medicine and Hygiene
Verified
Journal Article
Open access
HKHirotomo Kato
Hirotomo Kato
HUHiroshi Uezato
Hiroshi Uezato
KKKen Katakura
Ken Katakura
MCManuel Calvopiña
Manuel Calvopiña
JMJorge Marco
Jorge Marco
YHYoshihisa Hashiguchi
Yoshihisa Hashiguchi
The surveillance of prevalent Leishmania and sand fly species in endemic areas is important for prediction of the risk and expansion of leishmaniasis. In this study, we developed a polymerase chain reaction (PCR)-based method for detection of Leishmania minicircle DNA within individual sand flies. Using this method, we detected minicircle DNA in 6 (3.3%) of 183 sand flies, while 5 (3.5%) of 143 were positive for Leishmania promastigotes in the same areas by microscopic examination. The species were identified as Leishmania (Leishmania) mexicana by nucleotide sequencing of the cytochrome b gene. Additionally, all the Leishmania-positive sand flies were identified as Lutzomyia ayacuchensis by the restriction enzyme digestion of the PCR-amplified 18S ribosomal RNA gene fragments. Since this combined method is relatively easy and can process a large number of samples, it will be a powerful tool for the rapid identification of prevalent sand fly and Leishmania species as well as monitoring the infection rate in sand fly populations in endemic areas.

1 April 2014 in Acta Tropica
Verified
Journal Article
Closed access
CNChukwunonso Nzelu
Chukwunonso Nzelu
EGEduardo A. Gomez
Eduardo A. Gomez
ALAbraham Caceres Lazaro
Abraham Caceres Lazaro
TSTatsuya Sakurai
Tatsuya Sakurai
LMLuiggi Martini-Robles
Luiggi Martini-Robles
HKHirotomo Kato
Hirotomo Kato

1 May 2015 in Acta Tropica
Verified
Journal Article
Closed access
CNChukwunonso Nzelu
Chukwunonso Nzelu
ALAbraham Caceres Lazaro
Abraham Caceres Lazaro
MAMartín J. Arrunátegui-Jiménez
Martín J. Arrunátegui-Jiménez
MLMáximo F. Lañas-Rosas
Máximo F. Lañas-Rosas
HYHenrry H. Yañez-Trujillano
Henrry H. Yañez-Trujillano
HKHirotomo Kato
Hirotomo Kato

1 November 2000 in The Journal of Immunology
Verified
Journal Article
Open access
PDF file
TKToshiya Koga
Toshiya Koga
JMJerry R. McGhee
Jerry R. McGhee
HKHirotomo Kato
Hirotomo Kato
RKRie Kato
Rie Kato
HKHiroshi Kiyono
Hiroshi Kiyono
KFKohtaro Fujihashi
Kohtaro Fujihashi
Despite recent advances in the cellular and molecular analysis of induction and regulation of mucosal immune responses, little is yet known about differences which occur in aging. To address this important issue, we have compared the mucosal and systemic immune responses of aged (12- to 14-mo- or 2-year-old) and young adult (6- to 8-wk-old) C57BL/6 mice. Both aged and young mice were immunized weekly with three oral doses of 1 mg of OVA and 10 μg of cholera toxin (CT) as mucosal adjuvant. Both groups of mice over 1 or 2 years of age showed reduced levels of Ag-specific mucosal or systemic immune responses at day 21. An Ag-specific B cell enzyme-linked immunospot assay confirmed these results at the cellular level. When the Ag-induced cytokine responses were examined at both protein and mRNA levels, CD4+ T cells from spleen and Peyer’s patches of young adult mice revealed elevated levels of IL-4 production; however, these cytokine responses were significantly diminished in aged mice. In contrast to mucosal immunization, mice s.c. immunized with OVA plus CT resulted in impaired OVA-specific but intact CT B subunit-specific immune responses in 12- to 14-mo-old mice although the responses to both Ags were depressed in 2-year-old mice. These results provide the first evidence that the development of age-associated alterations possibly occurs earlier in the mucosal immune system than in the systemic immune compartment.